• Home
  •  / Smith & Nephew

Smith & Nephew

OverviewSuggest Edit

Smith & Nephew is a medical technology company. It operates in three main segments: Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. The company offers sports medicine joint repair products for surgeons, arthroscopic enabling technologies for healthcare providers, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, electromechanical and mechanical tissue resection devices, etc. 

TypePublic
Founded1856
HQTN, USMap
Websitesmith-nephew.com
Overall CultureA-More
View Jobs (954)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2017)15,000
Job Openings954
Revenue (FY, 2018)£3.7 B(+3%)
Share Price (Jul 2021)£14.6
Cybersecurity ratingCMore

Key People/Management at Smith & Nephew

Roland Diggelmann

Roland Diggelmann

Chief Executive Officer & Director
Brad Cannon

Brad Cannon

President Sports Medicine and Ear, Nose and Throat
Anne-Françoise Nesmes

Anne-Françoise Nesmes

Chief Financial Officer & Director
Elga Lohler

Elga Lohler

Chief Human Resources Officer
Erik Engstrom

Erik Engstrom

Independent Non-Executive Director
Mark Gladwell

Mark Gladwell

President, Global Operations
Show more

Smith & Nephew Office Locations

Smith & Nephew has offices in Andover, Austin, Durham, Fort Worth and in 2 other locations
São Paulo, BR
Av. do Café, 277
Andover, MA, US
150 Minuteman Rd
Austin, TX, US
7000 W William Cannon Dr
Durham, NC, US
Carlisle Place, 4721 Emperor Blvd #100
Fort Worth, TX, US
3909 Hulen St
Saint Petersburg, FL, US
970 Lake Carillon Dr #110
Show all (7)

Smith & Nephew Financials and Metrics

Smith & Nephew Revenue

Embed Graph
View revenue for all periods
Smith & Nephew's revenue was reported to be £3.72 b in FY, 2018 which is a 2.9% increase from the previous period.
GBP

Revenue (FY, 2018)

3.7b

Revenue growth (FY, 2017 - FY, 2018), %

2.9%

Gross profit (FY, 2018)

2.7b

Gross profit margin (FY, 2018), %

73.5%

Net income (FY, 2018)

502.7m

EBITDA (FY, 2018)

838.6m

EBIT (FY, 2018)

654.4m

Market capitalization (30-Jul-2021)

12.9b

Closing stock price (30-Jul-2021)

14.6

Cash (31-Dec-2018)

276.8m

EV

12.7b
Smith & Nephew's current market capitalization is £12.9 b.
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.1b1.0b1.1b1.1b1.1b1.1b1.1b1.2b1.2b1.4b1.4b2.0b2.9b3.2b3.6b3.4b3.6b3.7b

Revenue growth, %

(2%)1%6%1%(5%)3%6%6%13%1%43%11%13%(5%)7%3%

Cost of goods sold

472.6m446.1m453.3m479.6m456.8m350.2m329.9m345.1m334.8m361.0m1.1b600.7m724.8m797.5m883.4m923.3m946.3m984.2m

Gross profit

596.6m602.0m600.1m640.3m677.9m731.5m780.0m833.8m913.7m1.0b292.0m1.4b2.1b2.4b2.7b2.5b2.7b2.7b
show all
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

80.5m57.1m49.9m100.5m24.6m30.0m22.5m26.0m32.6m88.0m177.0m102.7m90.3m63.8m92.8m72.6m128.1m276.8m

Accounts Receivable

218.7m219.9m233.1m241.8m246.2m224.4m222.6m246.0m273.5m323.0m322.0m468.3m616.1m664.3m751.3m717.2m800.7m837.1m

Inventories

229.8m225.7m242.4m237.6m228.2m232.2m229.5m230.6m284.9m355.0m316.0m504.0m662.8m810.5m940.6m903.0m988.8m1.1b

Current Assets

564.5m561.3m570.9m619.2m530.6m525.4m532.7m591.1m679.3m937.0m840.0m1.2b1.5b1.7b1.9b1.8b2.1b2.3b
show all
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

120.7m113.7m93.7m104.8m205.2m129.6m112.1m148.1m125.2m170.0m201.0m191.0m366.3m343.8m316.9m569.1m581.6m502.7m

Cash From Operating Activities

189.3m181.7m161.9m198.1m204.0m191.9m209.3m214.5m226.6m147.0m190.0m264.7m571.3m468.7m796.1m616.3m826.5m705.9m

Dividends Paid

66.5m69.0m69.2m72.5m456.9m42.9m44.6m46.1m47.8m50.0m49.0m62.8m157.5m164.0m202.5m195.3m

Cash From Financing Activities

40.4m(19.7m)158.7m17.8m94.8m(93.1m)(16.9m)(22.0m)(196.0m)209.7m(328.1m)691.8m(431.3m)(384.0m)(329.1m)(281.3m)
show all
GBPFY, 1996

Financial Leverage

1.9 x
Show all financial metrics

Smith & Nephew Operating Metrics

Smith & Nephew's Training Provided, no. of people was reported to be 90 k in FY, 2016.
FY, 2016

Training Provided, no. of people

90 k
Show all operating metrics

Smith & Nephew Acquisitions / Subsidiaries

Company NameDateDeal Size
Integra LifeSciencesSeptember 29, 2020$240 m
Osiris TherapeuticsMarch 15, 2019$600 m

Smith & Nephew Revenue Breakdown

Embed Graph

Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other

Smith & Nephew Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

Learn more about our premium products
SecurityScorecard logo

Smith & Nephew Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

Learn more about our premium products
CSRHub logo

Smith & Nephew Online and Social Media Presence

Smith & Nephew's Trends

Embed Graph

Smith & Nephew Company Culture

  • Overall Culture

    A-

    73/100

  • CEO Rating

    A+

    79/100

  • Compensation

    A+

    89/100

  • Diversity

    A-

    76/100

Learn more on Comparably

Smith & Nephew News and Updates

April 29, 2021

London Markets: Earnings from Smith & Nephew, Standard Chartered and Unilever help drive FTSE 100 back to 7,000

London stocks were setting up for the best session in five on Thursday, after upbeat results from a number of blue chips, including Smith & Nephew, Unilever and Royal Dutch Shell.
March 18, 2021

North America Biofilms Treatment Market 2020-2027 with Smith & Nephew, MiMedx, ConvaTec Group Dominating

Dublin, March 18, 2021 (GLOBE NEWSWIRE) -- The "North America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Wound; End User; and Country" report has been added to ResearchAndMarkets.com's offering. North America Biofilms Treatment market is expected…
January 15, 2021

Global NPWT Devices and Accessories Market Analysis and Forecast Model, Featuring Key Players Smith & Nephew plc, Acelity L.P. Inc.,Molnlycke Health Care AB and Paul Hartmann AG

Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "NPWT Devices and Accessories (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering. This model discusses in detail the impact of COVID-19 on the NPWT D…
September 29, 2020

Smith & Nephew buying Integra LifeSciences unit

Smith & Nephew said it's buying the extremity orthopedics unit of Integra LifeSciences for $240 million in cash. Smith & Nephew said the deal will provide entry into the shoulder replacement and foot and ankle segment. The business generated revenue of $90 million in 2019 and traded at a …
July 01, 2020

Smith & Nephew spies recovery despite falling sales

Medical technology firm Smith & Nephew said it expects to slowly recover from the impact of the coronavirus pandemic, as The post Smith & Nephew spies recovery despite falling sales appeared first on CityAM.
February 20, 2020

London Markets: Smith & Nephew stands out in otherwise struggling London stock market

London stocks struggled for direction on Thursday, as investors assessed fresh coronavirus risk, with Smith & Nephew PLC standing out with gains after upbeat results.
Show more

 Smith & Nephew Frequently Asked Questions

  • When was Smith & Nephew founded?

    Smith & Nephew was founded in 1856.

  • Who are Smith & Nephew key executives?

    Smith & Nephew's key executives are Roland Diggelmann, Brad Cannon and Anne-Françoise Nesmes.

  • How many employees does Smith & Nephew have?

    Smith & Nephew has 15,000 employees.

  • What is Smith & Nephew revenue?

    Latest Smith & Nephew annual revenue is £3.7 b.

  • What is Smith & Nephew revenue per employee?

    Latest Smith & Nephew revenue per employee is £247.9 k.

  • Who are Smith & Nephew competitors?

    Competitors of Smith & Nephew include Zimmer Biomet, Integer Holdings and Stryker.

  • Where are Smith & Nephew offices?

    Smith & Nephew has offices in Andover, Austin, Durham, Fort Worth and in 2 other locations.

  • How many offices does Smith & Nephew have?

    Smith & Nephew has 7 offices.